Gujarat startup conclave 2025 sees 84 MoUs, Rs 232 crore investments

Addressing the concluding session, Gujarat Higher and Technical Education Minister Rushikesh Patel said that unicorns, investors, industrialists and entrepreneurs from across the country participated in the conclave.

“New directions will open new doors for students who are studying in technology-core-emerging branches… through innovation and new ideas, today’s youth has become capable of providing employment to others. They are making a significant contribution to realising Prime Minister Narendra Modi’s dream of a developed India of 2047 by becoming self-reliant and using technology,” a government statement quoted Patel as saying.

By using indigenous technology, India has the power to not only make a jet but a super jet aircraft, he said. “The Gujarat government has always been committed to providing strong support to startups. i-Hub (an initiative of the state government) is proving to be an important platform to promote the ventures of the youth of Gujarat. In order to promote the new innovative ideas of the youth, a region-wise i-Hub will be created in Gujarat in the near future. By creating i-Hubs according to the region, all the facilities will be available from the centre nearest to their village to convert the new ideas of the youth of the remotest villages into reality,” the minister added.

He also appealed to investors to invest more in the energy, new ideas and new ventures of the youth.

BioScan Research, co-founded by Gujarat’s Shilpa Malik, was part of the Startup Conclave 2025. The startup develops medical devices that facilitate the early diagnosis of life-threatening diseases, saving countless lives.

Reflecting on the journey of BioScan Research Private Limited, Malik said, “A member of our family experienced a traumatic brain injury, and during his treatment, we realised that the real challenge was not the injury itself, but the lack of early detection”.

“Many patients suffer further complications because their conditions are not diagnosed promptly. This experience became our motivation. Drawing on our technical expertise, we decided to establish a start-up dedicated to developing medical devices for early diagnosis,” she said.

“We received full support from i-Create, an organisation under the Government of Gujarat that provides financial assistance to tech-based start-ups. After investing four to five years in research, we established BioScan Research. Over two years of clinical research, tests were conducted on 1,500 patients, and over 11,000 brain scans were performed. After these successful trials, the device was officially launched for commercial use,” Malik added.

Shilpa Malik said that around 70 units of the device have been sold across India so far.

“The medical device demonstrates a performance accuracy of 95 per cent and a sensitivity of 97 per cent. The device has received an excellent response from government departments, with most sales going to primary health centres, community health centres, and trauma centres. Its high accuracy has also earned the trust of doctors,” the release added.

BioScan Research Private Limited was established in September 2017 in Ahmedabad by co-founders Shilpa Malik and Anupam Lavania. Previously, Malik worked as a scientist in the Defence Research and Development Organisation (DRDO), contributing to the design and management of military sensor systems. She is Chief Technology Officer of BioScan Research and is responsible for developing, testing, manufacturing, and selling medical devices that enable non-invasive, early diagnosis of life-threatening conditions such as traumatic brain injury.

From the homepage

Sonam Wangchuk indulging in activities ‘prejudicial to national security’: Leh administration to Supreme Court

Delhi News Live Updates: AQI in Delhi turns poor, first stage restrictions under GRAP activated

After World Bank, IMF also cuts India’s FY27 GDP growth forecast by 20 bps